<VariationArchive VariationID="631972" VariationName="NM_000426.4(LAMA2):c.5290dup (p.Glu1764fs)" VariationType="Duplication" Accession="VCV000631972" Version="16" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-29" DateCreated="2019-05-27" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="620211" VariationID="631972">
      <GeneList>
        <Gene Symbol="LAMA2" FullName="laminin subunit alpha 2" GeneID="3908" HGNC_ID="HGNC:6482" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="128883138" stop="129516566" display_start="128883138" display_stop="129516566" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="129204285" stop="129837710" display_start="129204285" display_stop="129837710" Strand="+" />
          </Location>
          <OMIM>156225</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000426.4(LAMA2):c.5290dup (p.Glu1764fs)</Name>
      <CanonicalSPDI>NC_000006.12:129393094:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q22.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="129393094" stop="129393095" display_start="129393094" display_stop="129393095" variantLength="1" positionVCF="129393094" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="129714239" stop="129714240" display_start="129714239" display_stop="129714240" variantLength="1" positionVCF="129714239" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <ProteinChange>E1764fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.129714245dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.129714245dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.129393100dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.129393100dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008678.1" sequenceAccession="NG_008678" sequenceVersion="1" change="g.514960dup">
            <Expression>NG_008678.1:g.514960dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000426.4" sequenceAccession="NM_000426" sequenceVersion="4" change="c.5290dup" MANESelect="true">
            <Expression>NM_000426.4:c.5290dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000417.3" sequenceAccession="NP_000417" sequenceVersion="3" change="p.Glu1764fs">
            <Expression>NP_000417.3:p.Glu1764fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079823.2" sequenceAccession="NM_001079823" sequenceVersion="2" change="c.5290dup">
            <Expression>NM_001079823.2:c.5290dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001073291.2" sequenceAccession="NP_001073291" sequenceVersion="2" change="p.Glu1764fs">
            <Expression>NP_001073291.2:p.Glu1764fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_409" sequenceAccession="LRG_409">
            <Expression>LRG_409:g.514960dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_409t1" sequenceAccession="LRG_409t1">
            <Expression>LRG_409t1:c.5290dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_409p1" sequenceAccession="LRG_409p1" change="p.Glu1764fs">
            <Expression>LRG_409p1:p.Glu1764fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000426.3" sequenceAccession="NM_000426" sequenceVersion="3" change="c.5290dupG">
            <Expression>NM_000426.3:c.5290dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1415944134" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000426.4(LAMA2):c.5290dup (p.Glu1764fs) AND Congenital muscular dystrophy due to partial LAMA2 deficiency" Accession="RCV000778777" Version="11">
        <ClassifiedConditionList TraitSetID="3942">
          <ClassifiedCondition DB="MedGen" ID="C1842898">Congenital muscular dystrophy due to partial LAMA2 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-12-10" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000426.4(LAMA2):c.5290dup (p.Glu1764fs) AND LAMA2-related muscular dystrophy" Accession="RCV000796627" Version="15">
        <ClassifiedConditionList TraitSetID="9616">
          <ClassifiedCondition DB="MedGen" ID="C5679788">LAMA2-related muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000426.4(LAMA2):c.5290dup (p.Glu1764fs) AND Merosin deficient congenital muscular dystrophy" Accession="RCV002249477" Version="9">
        <ClassifiedConditionList TraitSetID="3941">
          <ClassifiedCondition DB="MedGen" ID="C1263858">Merosin deficient congenital muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-06-07" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-07" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2019-05-27" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18700894</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20207543</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30301903</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32904964</ID>
        </Citation>
        <DescriptionHistory Dated="2019-08-13">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16601" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Laminin alpha 2-related dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">LAMA2-related muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0100228" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LAMA2-RD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The clinical manifestations of LAMA2 muscular dystrophy (LAMA2-MD) comprise a continuous spectrum ranging from severe congenital muscular dystrophy type 1A (MDC1A) to milder late-onset LAMA2-MD. MDC1A is typically characterized by neonatal profound hypotonia, poor spontaneous movements, and respiratory failure. Failure to thrive, gastroesophageal reflux, aspiration, and recurrent chest infections necessitating frequent hospitalizations are common. As disease progresses, facial muscle weakness, temporomandibular joint contractures, and macroglossia may further impair feeding and can affect speech. In late-onset LAMA2-MD onset of manifestations range from early childhood to adulthood. Affected individuals may show muscle hypertrophy and develop a rigid spine syndrome with joint contractures, usually most prominent in the elbows. Progressive respiratory insufficiency, scoliosis, and cardiomyopathy can occur.</Attribute>
                <XRef ID="NBK97333" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22675738</ID>
                <ID Source="BookShelf">NBK97333</ID>
              </Citation>
              <XRef ID="C5679788" DB="MedGen" />
              <XRef ID="MONDO:0100228" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3941" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3057" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Merosin deficient congenital muscular dystrophy</ElementValue>
                <XRef ID="Muscular+dystrophy+congenital%2C+merosin+negative/4985" DB="Genetic Alliance" />
                <XRef ID="111503008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital merosin-deficient muscular dystrophy 1A</ElementValue>
                <XRef ID="MONDO:0011925" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy congenital, merosin negative</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MDC1A</ElementValue>
                <XRef Type="MIM" ID="607855" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3843" />
                <XRef ID="3843" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ISCCCMD, 2010">
                <ID Source="PubMed">21078917</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22420014</ID>
                <ID Source="BookShelf">NBK84550</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22675738</ID>
                <ID Source="BookShelf">NBK97333</ID>
              </Citation>
              <XRef ID="258" DB="Orphanet" />
              <XRef ID="C1263858" DB="MedGen" />
              <XRef ID="MONDO:0011925" DB="MONDO" />
              <XRef Type="MIM" ID="607855" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3942" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9090" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital muscular dystrophy due to partial LAMA2 deficiency</ElementValue>
              </Name>
              <XRef ID="C1842898" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1790217" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="803057" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000915146" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30301903</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20207543</ID>
          </Citation>
          <Comment>The LAMA2 c.5290dupG (p.Glu1764GlyfsTer3) variant results in a frameshift and is predicted to result in premature termination of the protein. It has been reported in two unrelated individuals with congenital muscular dystrophy, including in one in a homozygous state and in one in a compound heterozygous state (Geranmayeh et al. 2010; Ge et al. 2018). Control data are unavailable for this variant and the variant is not found in the 1000 Genomes Project, the Exome Sequencing Project, Exome Aggregation Consortium, or the Genome Aggregation Database. Based on the evidence and the potential impact of frameshift variants, the p.Glu1764GlyfsTer3 variant is classified as likely pathogenic for LAMA2-related congenital muscular dystrophy. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" alternateAllele="CG" referenceAllele="C" start="129714239" stop="129714239" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000426.3:c.5290dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Congenital muscular dystrophy due to partial LAMA2 deficiency</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1842898" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4933330" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-28" DateCreated="2022-05-28">
        <ClinVarSubmissionID localKey="NC_000006.12:g.129393094_129393095insG|OMIM:607855" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002516642" DateUpdated="2022-05-28" DateCreated="2022-05-28" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.12:g.129393094_129393095insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607855" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7846320" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000426.4:c.5290dup|OMIM:607855" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004190497" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000426.4:c.5290dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607855" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1829990" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="3003658|MedGen:CN117977" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000936147" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20207543</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30301903</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18700894</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32904964</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 631972). This premature translational stop signal has been observed in individuals with autosomal recessive congenital muscular dystrophy (PMID: 20207543, 30301903). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu1764Glyfs*3) in the LAMA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMA2 are known to be pathogenic (PMID: 18700894, 32904964).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.129714239_129714240insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN117977" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4933330" TraitType="Disease" MappingType="XRef" MappingValue="607855" MappingRef="OMIM">
        <MedGen CUI="C1263858" Name="Merosin deficient congenital muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7846320" TraitType="Disease" MappingType="XRef" MappingValue="607855" MappingRef="OMIM">
        <MedGen CUI="C1263858" Name="Merosin deficient congenital muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1829990" TraitType="Disease" MappingType="XRef" MappingValue="CN117977" MappingRef="MedGen">
        <MedGen CUI="C5679788" Name="LAMA2-related muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1790217" TraitType="Disease" MappingType="Name" MappingValue="Congenital muscular dystrophy due to partial LAMA2 deficiency" MappingRef="Preferred">
        <MedGen CUI="C1842898" Name="Congenital muscular dystrophy due to partial LAMA2 deficiency" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001526011</Accession>
        <Description>not specified</Description>
      </SCV>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002023885</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

